analytica 2018 - On its way to Personalized Medicine
The study of cell cultures in analytic and diagnostic procedures is an important building block for biotechnologists. One of the targets is to minimize the side effects of different medications. For a few years now there have been initial specific approaches to tailoring medication to humans and their diseases individually. The goal: successful and tailored treatment options through the analysis of genetically different tumour cells, for example. This Personalized Medicine is intended to give a more precise understanding of diseases and their treatment options. From the individual cell analysis, data is digitally collected – to enable the development of suitable medication. This is a special challenge that analytics will have to face in the future. Analytica 2018 is the platform on which the latest expertise is presented and discussed in the field of Personalized Medicine.